Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 6
1989 14
1990 22
1991 19
1992 28
1993 38
1994 48
1995 64
1996 68
1997 48
1998 58
1999 72
2000 54
2001 36
2002 41
2003 39
2004 35
2005 27
2006 34
2007 28
2008 44
2009 42
2010 43
2011 36
2012 35
2013 32
2014 25
2015 23
2016 11
2017 13
2018 5
2019 4
2020 2
2021 3
2022 9
2023 5
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,081 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Zidovudine use in pregnancy and congenital malformations.
Rough K, Sun JW, Seage GR 3rd, Williams PL, Huybrechts KF, Bateman BT, Hernandez-Diaz S. Rough K, et al. AIDS. 2017 Jul 31;31(12):1733-1743. doi: 10.1097/QAD.0000000000001549. AIDS. 2017. PMID: 28537936 Free PMC article. Review.
OBJECTIVE: There is inconsistent evidence that zidovudine use during pregnancy increases overall, cardiac, and male genital malformations. ...METHODS: Using MAX data (2000-2010), we identified pregnant women with HIV treated with antiretroviral therapy (ART). Women with at …
OBJECTIVE: There is inconsistent evidence that zidovudine use during pregnancy increases overall, cardiac, and male genital malformat …
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.
Paton NI, Musaazi J, Kityo C, Walimbwa S, Hoppe A, Balyegisawa A, Asienzo J, Kaimal A, Mirembe G, Lugemwa A, Ategeka G, Borok M, Mugerwa H, Siika A, Odongpiny ELA, Castelnuovo B, Kiragga A, Kambugu A; NADIA Trial Team. Paton NI, et al. Lancet HIV. 2022 Jun;9(6):e381-e393. doi: 10.1016/S2352-3018(22)00092-3. Epub 2022 Apr 20. Lancet HIV. 2022. PMID: 35460601 Free article. Clinical Trial.
BACKGROUND: WHO guidelines recommend dolutegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs) for second-line HIV therapy, with NRTI switching from first-line tenofovir to zidovudine. We aimed to examine whether dolutegravir is non-inferior to darunavir, t …
BACKGROUND: WHO guidelines recommend dolutegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs) for second-line HIV therapy, …
Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
Shafiee A, Seighali N, Taherzadeh-Ghahfarokhi N, Mardi S, Shojaeian S, Shadabi S, Hasani M, Haghi S, Mozhgani SH. Shafiee A, et al. Virol J. 2023 Jun 7;20(1):118. doi: 10.1186/s12985-023-02077-0. Virol J. 2023. PMID: 37287047 Free PMC article.
There is no known treatment for ATLL as of yet. However, it is recommended to use Zidovudine and Interferon Alfa-based regimens (AZT/IFN), chemotherapy, and stem cell transplant. This study aims to review the outcome of patients with different subtypes of ATLL treated with …
There is no known treatment for ATLL as of yet. However, it is recommended to use Zidovudine and Interferon Alfa-based regimens (AZT/ …
Zidovudine (Retrovir) update.
Rachlis AR. Rachlis AR. CMAJ. 1990 Dec 1;143(11):1177-85. CMAJ. 1990. PMID: 2224694 Free PMC article. Review.
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. ...After a search of MEDLINE for pertinent articles published since 1985, controlled studies and studies of long-term zidovudine ther …
Zidovudine (AZT) is the first antiretroviral agent to be licensed for the treatment of human immunodeficiency virus (HIV) infection. …
Zidovudine: a targeted therapy for endemic Burkitt's lymphoma.
Kurokawa M, Andela V, Ghosh S, Barreto JE, Harrington W. Kurokawa M, et al. East Afr Med J. 2005 Sep;82(9 Suppl):S150-4. doi: 10.4314/eamj.v82i9.9387. East Afr Med J. 2005. PMID: 16619691
DATA EXTRACTION: A systematic review to identify studies relating to Zidovudine, EBV+ and Burkitt's lymphoma, indicating antiviral agents zidovudine targeting BL in a unique and novel mechanisms. ...Furthermore, the addition of the widely available and inexpensive a …
DATA EXTRACTION: A systematic review to identify studies relating to Zidovudine, EBV+ and Burkitt's lymphoma, indicating antiviral ag …
Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis.
Alzate Angel JC, Duque Molina MM, García García HI. Alzate Angel JC, et al. Colomb Med (Cali). 2017 Jun 30;48(2):70-81. Colomb Med (Cali). 2017. PMID: 29021641 Free PMC article. Review.
METHODS: Systematic review and network meta-analysis of randomized clinical trials comparing fixed doses of Tenofovir Disoproxil Fumarate / Emtricitabine (TDF/FTC), Abacavir / Lamivudine (ABC/3TC) and Zidovudine / Lamivudine (ZDV/3TC). RESULTS: Seven clinical trials met th …
METHODS: Systematic review and network meta-analysis of randomized clinical trials comparing fixed doses of Tenofovir Disoproxil Fumarate / …
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS. Shey MS, et al. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD005481. doi: 10.1002/14651858.CD005481.pub3. Cochrane Database Syst Rev. 2013. PMID: 23543540 Free PMC article. Review.
The RCTs compared co-formulated abacavir-lamivudine-zidovudine to treatment based on efavirenz (NNRTI), nelfinavir (PI), atazanavir (PI), and co-formulated lopinavir-ritonavir (PI), respectively. ...However, the results showed significant heterogeneity (I(2)=79%); with co- …
The RCTs compared co-formulated abacavir-lamivudine-zidovudine to treatment based on efavirenz (NNRTI), nelfinavir (PI), atazanavir ( …
Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naive individuals.
Spaulding A, Rutherford GW, Siegfried N. Spaulding A, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008651. doi: 10.1002/14651858.CD008651. Cochrane Database Syst Rev. 2010. PMID: 20687097 Review.
Two common medications given in first-line antiretroviral therapy are the nucleoside reverse transcriptase inhibitors (NRTI) stavudine (d4T) or zidovudine (AZT). OBJECTIVES: To assess the efficacy of d4T compared to AZT in combination with one NRTI and one non-nucleoside r …
Two common medications given in first-line antiretroviral therapy are the nucleoside reverse transcriptase inhibitors (NRTI) stavudine (d4T) …
Half-dose zidovudine.
de Truchis P, Salmon D, Matheron S, Jelasko P, Rozenbaum W, Leport C. de Truchis P, et al. Lancet. 1991 May 4;337(8749):1109. doi: 10.1016/0140-6736(91)91766-n. Lancet. 1991. PMID: 1673539 Clinical Trial. No abstract available.
1,081 results

Searches related to "zidovudine"